bicistronic PEDF/CD46 gene therapy (Ikarovec)

N/A

Report date: 2025/06/11 10:50:17

Base Information

Drug Namebicistronic PEDF/CD46 gene therapy (Ikarovec)
Drug Alias NameIKC-159VAAV8-IKC-159V
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPlasminogen activator inhibitor 1 stimulantsMembrane cofactor protein stimulants
TargetsPlasminogen activator inhibitor 1Membrane cofactor protein
Therapy Area/IndicationsGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIkarovec Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIkarovec Ltd
Inactive CompaniesN/A
Active IndicationsGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A